PER3 rs10462020: Sleep Timing and Diurnal Preference
The rs10462020 polymorphism is a single-nucleotide variant located within the PER3 gene, which encodes an essential regulator of the human circadian rhythm. Research has linked this variant to individual variations in diurnal preference, particularly morningness versus eveningness chronotypes and susceptibility to delayed sleep phase syndrome. While it plays an influential role in circadian research, rs10462020 acts as a modest modifier alongside multiple genetic and lifestyle factors rather than a definitive determinant of sleep patterns.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| TT | This common genotype has been associated in candidate-gene studies with evening diurnal preference and a higher statistical likelihood of delayed sleep phase syndrome. Individuals with this genotype generally exhibit later natural sleep and wake times, although daily routines, light exposure, and lifestyle exert powerful modulating effects. | Informational |
| TG | Carriers of one copy of the G allele typically exhibit an intermediate diurnal preference, balancing tendencies toward early and late sleep timing. This heterozygous combination reflects an average circadian period when evaluated across population-level studies. | Informational |
| GG | Possession of two copies of the minor G allele has been associated with earlier sleep-wake patterns and morning diurnal preference. Research indicates this genotype correlates with earlier natural peak alertness and lower odds of delayed sleep phase traits. | Favorable |
Genomic Context and the rs10462020 Variant
The rs10462020 single-nucleotide polymorphism (SNP) is located in the coding region of the PER3 (period circadian regulator 3) gene on chromosome 1. Often designated as PER3C in circadian genetic literature, this missense variant involves a thymine (T) to guanine (G) substitution. This single-base alteration produces a valine-to-glycine amino acid change at residue 674 of the PER3 protein. By altering the structure of the resulting peptide, the variant can subtlely impact protein conformation and downstream molecular interactions within cell-autonomous clocks. While rs10462020 is often evaluated as an independent locus, researchers frequently study it as part of larger functional haplotypes alongside other PER3 polymorphisms, including variable number tandem repeats (VNTRs) and neighboring single-nucleotide changes.
Biological Function of the PER3 Clock Gene
The PER3 gene encodes a central component of the mammalian transcription-translation feedback loop that drives 24-hour biological cycles. Inside the suprachiasmatic nucleus of the hypothalamus and in peripheral tissues, PER proteins heterodimerize with CRY proteins, subsequently translocating back into the cell nucleus to repress their own transcription. Although mice lacking PER3 maintain basic circadian rhythms, human cellular and candidate-gene studies show that PER3 helps stabilize PER1 and PER2 proteins, thereby modulating the precision, amplitude, and period of cellular circadian timing. Disruptions or structural alterations in PER3 can shift the phase of melatonin secretion, body temperature cycles, and cognitive alertness across the day, influencing when an individual naturally feels inclined to sleep or awaken.
Associations with Sleep Phase and Diurnal Preference
Candidate-gene and cohort studies have repeatedly connected rs10462020 to differences in diurnal preference, commonly referred to as chronotype. In multiple behavioral sleep studies, the G allele has shown statistically significant associations with a morning preference, aligning individuals with earlier bedtimes and wake times. In contrast, the more prevalent T allele, especially in the TT genotype, has been correlated with an evening preference and a higher incidence of delayed sleep phase syndrome (DSPS), characterized by habitual sleep initiation several hours past conventional norms. However, genome-wide association studies (GWAS) analyzing complex chronotype traits in massive biobanks frequently report modest effect sizes, suggesting that while rs10462020 influences sleep timing, its clinical penetrance is conditional upon wider multi-gene haplotypes, light exposure, and social cues.
Population Prevalence and Allele Distribution
The rs10462020 variant is relatively common across global populations, with the minor G allele maintaining a frequency between roughly 0.15 and 0.25 across diverse ancestral groups. This widespread distribution confirms that both the T and G alleles represent natural human genetic variation rather than rare deleterious mutations. The homozygous TT state represents the most frequent genotype globally, followed by the heterozygous TG genotype, while the homozygous GG state is less commonly observed. Allele frequencies do show regional variability across continental populations, which circadian biologists note may influence how clock gene variants interact with environmental photoperiods at varying latitudes.
Interpretation and Practical Considerations
Knowing your rs10462020 genotype provides biological context regarding your innate circadian baseline, but it is not a clinical test or a medical diagnosis. Carrying the T allele does not doom a person to chronic sleep onset insomnia, nor does carrying the G allele guarantee effortless early rising. Genetic predispositions interact constantly with external zeitgebers, such as daylight exposure, evening blue light from screens, meal timing, and physical exercise. Readers experiencing severe day-to-day fatigue, excessive daytime sleepiness, or persistent difficulty synchronizing their sleep schedule should seek comprehensive evaluation by a board-certified sleep specialist, rather than making major lifestyle or chronotherapeutic adjustments based solely on individual genetic markers.
How common is this variant?
The minor G allele has a frequency of approximately 0.15 to 0.25 across global populations, making the TT genotype the most prevalent, followed by TG, while GG is the least frequent across most continental groups.
Frequently asked questions
Does having the rs10462020 T allele mean I have delayed sleep phase syndrome?
No. Carrying the T allele simply reflects a statistical correlation with later sleep preferences in candidate-gene cohorts. Delayed sleep phase syndrome is a formal medical condition diagnosed through clinical history and sleep monitoring, not by single genetic markers.
Can my PER3 rs10462020 genotype change over my lifetime?
Your underlying DNA sequence remains the same throughout your life. However, your chronotype naturally shifts as you age, often moving toward eveningness during adolescence and gradually shifting toward morningness in middle and older adulthood.
Is the PER3 rs10462020 variant considered a disease-causing mutation?
No, rs10462020 is a common polymorphism categorized as a benign behavioral trait modifier rather than a disease-causing mutation. It forms part of the normal spectrum of human biological variation controlling circadian timing.
How does rs10462020 interact with other sleep-related variants?
Sleep and circadian rhythms are polygenic traits influenced by dozens of clock genes such as CLOCK, PER1, PER2, and CRY1. The rs10462020 SNP often functions as part of multi-variant PER3 haplotypes, combining with other polymorphisms to produce additive effects on sleep phase.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10462020?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29